Effectiveness of Early Favipiravir Therapy in Hospitalised COVID-19 Patients

COVID-19 is a disease caused by a novel coronavirus with no specific, standard treatment. We investigated the clinical data of COVID-19 patients admitted to King Fahad Specialist Hospital (KFSH) in Buraydah by comparing the patients who were treated early with favipiravir (within 3 days of admission...

Descripción completa

Detalles Bibliográficos
Autores principales: Tawfik, Abdulrahman, Alzahrani, Abdulrahman, Alharbi, Sami, Almitairi, Jamal, Alzahrani, Arwa, Alshehri, Mohammed Ali, Aldughaim, Mohammed S., Alothaid, Hani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259373/
https://www.ncbi.nlm.nih.gov/pubmed/35812166
http://dx.doi.org/10.1155/2022/9240941

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259373/
https://www.ncbi.nlm.nih.gov/pubmed/35812166
http://dx.doi.org/10.1155/2022/9240941

Ejemplares similares